| MECVX | NPFCX | MECVX / NPFCX | |
| Total Expense Ratio | 1.42 | 1.47 | 97% |
| Annual Report Gross Expense Ratio | 1.42 | 1.47 | 97% |
| Fund Existence | 10 years | 25 years | - |
| Gain YTD | 9.446 | 7.617 | 124% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 137M | 166B | 0% |
| Annual Yield % from dividends | 0.00 | 0.33 | - |
| Returns for 1 year | 7.14 | 7.64 | 94% |
| Returns for 3 years | 33.88 | 39.60 | 86% |
| Returns for 5 years | 1.49 | 10.82 | 14% |
| Returns for 10 years | 59.74 | 96.85 | 62% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JLGRX | 87.12 | 0.46 | +0.53% |
| JPMorgan Large Cap Growth R5 | |||
| CGTRX | 9.54 | 0.04 | +0.42% |
| Columbia Select Large Cap Growth Inst2 | |||
| ACREX | 13.62 | 0.05 | +0.37% |
| ACR Equity International Fund I Shares | |||
| ASPCX | 27.77 | 0.10 | +0.36% |
| Alger Spectra C | |||
| GTLLX | 34.55 | 0.09 | +0.26% |
| Glenmede Disciplined US Growth Eq Ptf | |||